Login / Signup

Vaccine Effectiveness of BNT162b2 and CoronaVac against SARS-CoV-2 Omicron BA.2 in CKD.

Franco Wing Tak ChengVincent Ka Chun YanEric Yuk Fai WanCeline Sze Ling ChuiFrancisco Tsz Tsun LaiCarlos King-Ho WongXue LiCheyenne I Ying ChanBoyuan WangSydney Chi-Wai TangIan Chi Kei Ck WongEsther Wai Yin Chan
Published in: Clinical journal of the American Society of Nephrology : CJASN (2023)
A dose-response relationship was observed between the number of BNT162b2 or CoronaVac doses and the effectiveness against COVID-19 infection and related comorbidity in the CKD population.
Keyphrases
  • sars cov
  • chronic kidney disease
  • randomized controlled trial
  • systematic review
  • respiratory syndrome coronavirus
  • coronavirus disease